Biomater. Sci., 2023, 11,6545-6560
DOI: 10.1039/D3BM00609C, Paper
DOI: 10.1039/D3BM00609C, Paper
Open Access
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Cara Moloney, Fatemeh Mehradnia, Robert J. Cavanagh, Asmaa Ibrahim, Amanda K. Pearce, Alison A. Ritchie, Philip Clarke, Ruman Rahman, Anna M. Grabowska, Cameron Alexander
The therapeutic efficacy of nanomedicines is highly dependent on their access to target sites in the body, and this in turn is markedly affected by their size, shape and transport properties in tissue.
The content of this RSS Feed (c) The Royal Society of Chemistry
The therapeutic efficacy of nanomedicines is highly dependent on their access to target sites in the body, and this in turn is markedly affected by their size, shape and transport properties in tissue.
The content of this RSS Feed (c) The Royal Society of Chemistry